Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN
Homo sapiens
State in the Current Structure
| Assembly | Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Associated Components | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|
| 1 | Protein monomer Monomer Protein × 1 PDB declaration: monomeric(1) Consistent with protein copy count | Chain A; UniProt 1–403 | Not recorded | PO4 PHOSPHATE ION × 2 | X-RAY DIFFRACTION X-ray crystallization conditions:VAPOR DIFFUSION;293 K;300 mM citrate | Resolution 3.20 Å R-free 0.296 |
Other States of the Same Protein in the Database
Each row is a biological assembly of the same UniProt protein in another PDB entry. The “Difference from current entry” column identifies evidence-level differences; no tag means the currently parsed fields agree.
| Other PDB | Difference from Current Entry 7JVX | Assembly / Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Non-polymers | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|---|
| 1D5R Crystal Structure of the PTEN Tumor Suppressor Deposited 1999-10-11 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
7–285(279 aa)
Fragment:RESIDUES 7-353
Chain A
310–353(44 aa)
Fragment:RESIDUES 7-353
|
Mutation:RESIDUES 286-309 ARE REPLACED BY VAL Mutation:RESIDUES 286-309 ARE REPLACED BY VAL | TLA L(+)-TARTARIC ACID × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;293 K;NA/K TARTRATE, 5% GLYCEROL, 100MM TRIS-CL, 10MM DTT, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 2.10 Å R-free 0.276 |
| 2KYL Solution structure of MAST2-PDZ complexed with the C-terminus of PTEN Deposited 2010-06-01 | Different construct Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain B
391–403(13 aa)
|
Not recorded | No recorded non-water small molecule |
SOLUTION NMR
NMR measurement conditions
pH 7.5;298 K;Ionic strength (raw mmCIF value) 0.2;Pressure ambient
NMR sample composition
0.6mM [U-100% 13C; U-100% 15N] PDZ-domain-1, 1.2mM PTEN-2, 90% H2O/10% D2O | 90% H2O/10% D2O
|
Resolution not provided |
| 4O1V SPOP Promotes Tumorigenesis by Acting as a Key Regulatory Hub in Kidney Cancer Deposited 2013-12-16 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain B
354–368(15 aa)
Fragment:UNP residues 354-368
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8.5;298 K;100 mM Tris, 100 mM sodium malonate, 36% PEG400, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 2.00 Å R-free 0.221 |
| 5BUG Crystal structure of human phosphatase PTEN oxidized by H2O2 Deposited 2015-06-03 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: Monomeric |
Chain A
14–351(338 aa)
Fragment:PTEN wt 14-351 delta 286-309
|
Mutation:Deletion 286-309 | TLA L(+)-TARTARIC ACID × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;0.1 M MES pH 6.5, 1.25 M L-tartrat, 7.5% glycerol
|
Resolution 2.40 Å R-free 0.211 |
| 5BUG Crystal structure of human phosphatase PTEN oxidized by H2O2 Deposited 2015-06-03 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein monomer Monomer;Protein × 1 PDB declaration: Monomeric |
Chain B
14–351(338 aa)
Fragment:PTEN wt 14-351 delta 286-309
|
Mutation:Deletion 286-309 | TLA L(+)-TARTARIC ACID × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;0.1 M MES pH 6.5, 1.25 M L-tartrat, 7.5% glycerol
|
Resolution 2.40 Å R-free 0.211 |
| 5BUG Crystal structure of human phosphatase PTEN oxidized by H2O2 Deposited 2015-06-03 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 3 Protein monomer Monomer;Protein × 1 PDB declaration: Monomeric |
Chain C
14–351(338 aa)
Fragment:PTEN wt 14-351 delta 286-309
|
Mutation:Deletion 286-309 | TLA L(+)-TARTARIC ACID × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;0.1 M MES pH 6.5, 1.25 M L-tartrat, 7.5% glycerol
|
Resolution 2.40 Å R-free 0.211 |
| 5BUG Crystal structure of human phosphatase PTEN oxidized by H2O2 Deposited 2015-06-03 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 4 Protein monomer Monomer;Protein × 1 PDB declaration: Monomeric |
Chain D
14–351(338 aa)
Fragment:PTEN wt 14-351 delta 286-309
|
Mutation:Deletion 286-309 | TLA L(+)-TARTARIC ACID × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;0.1 M MES pH 6.5, 1.25 M L-tartrat, 7.5% glycerol
|
Resolution 2.40 Å R-free 0.211 |
| 5BZX Crystal structure of human phosphatase PTEN treated with a bisperoxovanadium complex Deposited 2015-06-11 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
14–351(338 aa)
Fragment:PTEN wt 7-353 delta 286-309
|
Mutation:Deletion 286-309 | VO4 VANADATE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;0.1 M MES pH 6.5, 1.25 M L-tartrat, 7.5% glycerol
|
Resolution 2.50 Å R-free 0.204 |
| 5BZX Crystal structure of human phosphatase PTEN treated with a bisperoxovanadium complex Deposited 2015-06-11 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain B
14–351(338 aa)
Fragment:PTEN wt 7-353 delta 286-309
|
Mutation:Deletion 286-309 | TLA L(+)-TARTARIC ACID × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;0.1 M MES pH 6.5, 1.25 M L-tartrat, 7.5% glycerol
|
Resolution 2.50 Å R-free 0.204 |
| 5BZX Crystal structure of human phosphatase PTEN treated with a bisperoxovanadium complex Deposited 2015-06-11 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 3 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain C
14–351(338 aa)
Fragment:PTEN wt 7-353 delta 286-309
|
Mutation:Deletion 286-309 | VO4 VANADATE ION × 1 TLA L(+)-TARTARIC ACID × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;0.1 M MES pH 6.5, 1.25 M L-tartrat, 7.5% glycerol
|
Resolution 2.50 Å R-free 0.204 |
| 5BZX Crystal structure of human phosphatase PTEN treated with a bisperoxovanadium complex Deposited 2015-06-11 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 4 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain D
14–351(338 aa)
Fragment:PTEN wt 7-353 delta 286-309
|
Mutation:Deletion 286-309 | TLA L(+)-TARTARIC ACID × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;0.1 M MES pH 6.5, 1.25 M L-tartrat, 7.5% glycerol
|
Resolution 2.50 Å R-free 0.204 |
| 5BZZ Crystal structure of human phosphatase PTEN in its reduced state Deposited 2015-06-11 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
14–351(338 aa)
Fragment:PTEN wt 7-353 delta 286-309
|
Mutation:Deletion 286-309 | TLA L(+)-TARTARIC ACID × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;0.1 M MES pH 6.5, 1.25 M L-tartrate, 7.5% glycerol
|
Resolution 2.20 Å R-free 0.221 |
| 5BZZ Crystal structure of human phosphatase PTEN in its reduced state Deposited 2015-06-11 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain B
14–351(338 aa)
Fragment:PTEN wt 7-353 delta 286-309
|
Mutation:Deletion 286-309 | TLA L(+)-TARTARIC ACID × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;0.1 M MES pH 6.5, 1.25 M L-tartrate, 7.5% glycerol
|
Resolution 2.20 Å R-free 0.221 |
| 5BZZ Crystal structure of human phosphatase PTEN in its reduced state Deposited 2015-06-11 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 3 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain C
14–351(338 aa)
Fragment:PTEN wt 7-353 delta 286-309
|
Mutation:Deletion 286-309 | TLA L(+)-TARTARIC ACID × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;0.1 M MES pH 6.5, 1.25 M L-tartrate, 7.5% glycerol
|
Resolution 2.20 Å R-free 0.221 |
| 5BZZ Crystal structure of human phosphatase PTEN in its reduced state Deposited 2015-06-11 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 4 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain D
14–351(338 aa)
Fragment:PTEN wt 7-353 delta 286-309
|
Mutation:Deletion 286-309 | TLA L(+)-TARTARIC ACID × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;0.1 M MES pH 6.5, 1.25 M L-tartrate, 7.5% glycerol
|
Resolution 2.20 Å R-free 0.221 |
| 7JUK Crystal structure of PTEN with a tetra-phosphorylated tail (4p-crPTEN-13sp-T2, SDTTDSDPENEG) Deposited 2020-08-19 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
7–285(279 aa)
Chain A
310–353(44 aa)
Chain A
378–390(13 aa)
|
Not recorded | PO4 PHOSPHATE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;293 K;1.2 M DL-malic acid
|
Resolution 3.15 Å R-free 0.289 |
| 7JUL Crystal structure of non phosphorylated PTEN (n-crPTEN-13sp-T1, SDTTDSDPENEG) Deposited 2020-08-20 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
7–285(279 aa)
Chain A
310–353(44 aa)
Chain A
378–390(13 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;293.15 K;1:1 volume of well solution: 100 mM Bis-Tris propane pH 7.0, 1.2 M DL-malic acid
|
Resolution 2.53 Å R-free 0.234 |
| 7PC7 The PDZ domain of SNTG1 complexed with the acetylated PDZ-binding motif of PTEN Deposited 2021-08-03 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Insufficient information Heteromer;Protein × 2 PDB declaration: dimeric |
Chain E
394–403(10 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF) | CA CALCIUM ION × 6 GOL GLYCEROL × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;0.1 M Tris 8.5, 22 % v/v PEG Smear Broad
|
Resolution 2.10 Å R-free 0.218 |
| 7PC7 The PDZ domain of SNTG1 complexed with the acetylated PDZ-binding motif of PTEN Deposited 2021-08-03 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Insufficient information Heteromer;Protein × 2 PDB declaration: dimeric |
Chain F
394–403(10 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF) | CA CALCIUM ION × 6 GOL GLYCEROL × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;0.1 M Tris 8.5, 22 % v/v PEG Smear Broad
|
Resolution 2.10 Å R-free 0.218 |
| 8X3S Crystal structure of human WDR5 in complex with PTEN Deposited 2023-11-14 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain B
115–148(34 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;289 K;0.2 M lithium sulfate monohydrate, 0.1 M HEPES at pH 7.5, 25% w/v polyethylene glycol 3350
|
Resolution 1.87 Å R-free 0.259 |
10 other PDB entries and 20 assemblies. Open the comparison page and filter oligomeric states
View Construct and Data Evidence
| UniProt name | PTEN_HUMAN |
| Isoform | — |
| PDB entities | 1 |
| Chains and sequence ranges | Author chain A; PDBConstruct 1–422; UniProt 1–403 |